6-month Leuprolide Acetate for Monitoring Central Precocious Puberty Treatment Efficacy

被引：0
|
作者：
Silverman, Lawrence [1 ]
Boldt-Houle, Deborah M. [2 ]
Atkinson, Stuart N. [2 ]
机构：
[1] Goryeb Childrens Hosp, Morristown, NJ USA
[2] Tolmar Pharmaceut Inc, Buffalo Grove, IL USA
来源：
HORMONE RESEARCH IN PAEDIATRICS | 2022年 / 95卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4982
引用
收藏
页码：208 / 209
页数：2
相关论文
共 50 条
  • [31] Pharmacodynamics of leuprolide acetate stimulation testing in diagnosing central precocious puberty
    Chi, Carolyn H.
    Durham, Eileen
    Neely, E. Kirk
    HORMONE RESEARCH, 2009, 72 : 125 - 125
  • [32] Efficacy of Leuprolide Acetate 1-Month Depot for Central Precocious Puberty (CPP): Growth Outcomes During a Prospective, Longitudinal Study
    Lee, Peter A.
    Neely, E. Kirk
    Fuqua, John
    Yang, Di
    Larsen, Lois M.
    Mattia-Goldberg, Cynthia
    Chwalisz, Kristof
    INTERNATIONAL JOURNAL OF PEDIATRIC ENDOCRINOLOGY, 2011,
  • [33] Changes of thyroid function in girls with central precocious puberty after 6-month GnRH agonist treatment
    Huh, Rimm
    Chung, Lindsey Yoojin
    Nam, Hyo-Kyoung
    Rhie, Young-Jun
    Lee, Kee-Hyoung
    HORMONE RESEARCH IN PAEDIATRICS, 2019, 91 : 492 - 493
  • [34] 6-Month Subcutaneous Leuprolide Acetate Effectively Suppressed Rate of Bone Maturation and Increased Predicted Adult Height Without Significant Increase in BMI in Children with Central Precocious Puberty
    Klein, Karen
    Atkinson, Stuart
    Boldt-Houle, Deborah
    Eugster, Erica
    HORMONE RESEARCH IN PAEDIATRICS, 2021, 94 (SUPPL 2): : 104 - 105
  • [35] Effectiveness of leuprolide acetate therapy every three months in central precocious puberty
    Mericq G, M. Veronica
    Youlton R, Ronald
    Willshaw Z, M. Eugenia
    REVISTA MEDICA DE CHILE, 2006, 134 (07) : 821 - 826
  • [36] ASSESSMENT OF DEPOT LEUPROLIDE ACETATE DOSE-ADEQUACY FOR CENTRAL PRECOCIOUS PUBERTY
    COOK, JS
    DOTY, KL
    CONN, PM
    HANSEN, JR
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 74 (05): : 1206 - 1209
  • [37] Pharmacokinetic and Exposure–Response Analyses of Leuprolide Following Administration of Leuprolide Acetate 3-Month Depot Formulations to Children with Central Precocious Puberty
    Nael M. Mostafa
    Balakrishna Hosmane
    Lois M. Larsen
    Kristof Chwalisz
    Yi-Lin Chiu
    Rajendra S. Pradhan
    Clinical Drug Investigation, 2014, 34 : 441 - 448
  • [38] Leuprolide and triptorelin treatment in children with idiopathic central precocious puberty: an efficacy/tolerability comparison study
    Valenzise, M.
    Nasso, C.
    Scarfone, A.
    Rottura, M.
    Cafarella, G.
    Pallio, G.
    Visalli, G.
    Di Prima, E.
    Nasso, E.
    Squadrito, V.
    Wasniewska, M.
    Irrera, P.
    Arcoraci, V.
    Squadrito, F.
    FRONTIERS IN PEDIATRICS, 2023, 11
  • [39] Efficacy and safety of leuprolide acetate 6-month depot for suppression of testosterone in patients with prostate cancer
    Spitz, A.
    Young, J. M.
    Larsen, L.
    Mattia-Goldberg, C.
    Donnelly, J.
    Chwalisz, K.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2012, 15 (01) : 93 - 99
  • [40] Efficacy and safety of leuprolide acetate 6-month depot for suppression of testosterone in patients with prostate cancer
    A Spitz
    J M Young
    L Larsen
    C Mattia-Goldberg
    J Donnelly
    K Chwalisz
    Prostate Cancer and Prostatic Diseases, 2012, 15 : 93 - 99
12345